TAKEDA PHARMACEUTICAL CO LTD

CIK 0001395064 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols

TAK on NYSE, TKPHF on OTC

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal

Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$16.37M

Quarterly institutional holdings reported on Form 13F; not total AUM.

Forms 3/4/5 positions$119.8M

Reporting-owner positions with enough filing detail to estimate value.

Latest reported 13F value

13F

$16.37M

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Source: SEC Form 13FScope: U.S.-listed equity holdings

Forms 3/4/5 position value

3/4/5

$119.8M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest 13F holdings

13F

OVID EQ XLO STTK LYEL

+3 more

AMWL RANI LAB

Largest symbols in the latest parsed Form 13F information table.

Freshness: Latest parsed 13F period

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

DAWN PHAT OVID THRX XLO

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

OVID EQ XLO STTK LYEL AMWL RANI LAB

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

HLVX

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

OVID

How to read these SEC ownership signals

• Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
• Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
• Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.

At a glance Names, identifiers, and filing context for this profile. 2 identity fields

SEC industry group

Pharmaceutical Preparations (Office of Life Sciences)

Business address

1 1, Nihonbashi Honcho 2 Chome, Chuo Ku, Tokyo, Japan, 103-8668

TAKEDA PHARMACEUTICAL CO LTD investment portfolio